Erratum To: Role of Interleukin-6 as an Early Marker of Fat Embolism Syndrome: A Clinical Study

Clinical Orthopaedics and Related Research - United States
doi 10.1007/s11999-016-5210-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Fat Embolism Syndrome

The Southwest Respiratory and Critical Care Chronicles
2014English

Role of Dermatoglyphics as a Potential Diagnostic Marker for Periodontitis: A Clinical Study

IOSR Journal of Dental and Medical Sciences
2016English

Subarachnoidal Fat Droplet Deposition and Fat Embolism Syndrome

BMJ Case Reports
Medicine
2017English

Pharmacological Role and Clinical Applications of Interleukin-6 in Rheumatoid Disease

International Journal of Interferon, Cytokine and Mediator Research
AllergyImmunology
2010English

Concomitant Fat Embolism Syndrome and Pulmonary Embolism in a Patient With a Femoral Shaft Fracture

Acute Medicine & Surgery
2015English

Interleukin 6 as Inflammatory Marker and Insulin Resistance in Obese Kuwaiti Adolescents

Integrative Obesity and Diabetes
2017English

Fat Embolism Syndrome With Cerebral Involvement in a Multitrauma Patient

Turkiye Klinikleri Journal of Anesthesiology Reanimation
2018English

Role of Interleukin-6 and Interleukin-15 in Exercise

MOJ Immunology
2018English

Hyperintense Vessels: An Early MRI Marker of Reversible Cerebral Vasoconstriction Syndrome?

Cephalalgia
MedicineNeurology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy